
On December 11th, Yeahmobi, one of CoStone’s investment portfolio, has been approved for its public listing application by the GEM listing committee. Yeahmobi is an intelligent marketing service provider for corporate internationalization. The company is committed to provide customers with marketing promotion service across the globe. Currently Yeahmobi’s major business involves performance advertising, brand advertising and account management for major medias.
READ
On November 19, the IPO application of MEDPRIN(ipo 108577), one of CoStone Capital’s investment project, was approved by GEM Listing Committee. With Anhui Huaheng Biotechnology(831088) passed CSRC approval on November 17, CoStone has two companies launching IPO this week.
READ
Jean-Marie Lehn, one of the 1987 Nobel Laureates in Chemistry, praised Royole for its distinctive innovation of fully flexible display at the 3rd World Laurates Forum. Scientific research itself, in the eyes of this laureate, resembles Sci-Fi features, but Royole’s flexible human-machine interface (HMI) technology seems a reality directly out of SF novels, the laureate exclaimed after seeing Royole’s achievements.
READ

On November 6th, 2020, CoStone Capital’s portfolio company GalaxyCore, a leading Chinese senor maker of CMOS image and DDI display gets approved for its IPO, joining CoStone’s STAR Market portfolio of Effort (688165.SH), SinoMed (688108.SH), BrightGene (688166.SH), Jinhong Gas (688106.SH), Donglai Coating Technology (688129.SH).
READ
SmartMore, a China's AI computer vision solution provider for industrial manufacturing, completed a USD 100 million Series A financing round, becoming the youngest “quasi-unicorn” AI company. CoStone Capital is one of the investors.
READ
October 22th, 2010 marked the Listing Ceremony and Global Dealer Conference of Shenzhen Soling Industrial Co., Ltd., a moment witnessed by Soling’s dealers coming afar. Soling has kicked off its journey of listing after 19-year growth and became a stronger force in the industry which is geared up for a shining future.
READ

August 7th, China’s securities regulator approved the IPO registration of Donglai Coating Technology Co., Ltd. It then will be listed on the Shanghai Stock Exchange's sci-tech innovation board, commonly known as the STAR market, adding a fifth STAR company to CoStone’s portfolio.
READ

On June 16th, 2020, Suzhou Jinhong Gas (688106.SH), one of CoStone’s best portfolio companies, kicked off trading on the Nasdaq-style STAR Market of the Shanghai Stock Exchange (SSE).
READ
Snibe (300832.SZ), Shenzhen New Industries Biomedical Engineering Co., Ltd., a leading Chinese biomedical technology company, sees its price bump up to 24.5 USD/share. It has raised over 10bn USD. In late May, less than two weeks since its IPO, Snibe has attracted 194 renowned Chinese institutional capital managers. This week adds another 24. Over 200 renowned capital managers, by now, have been attracted by Snibe, the newly emerged Prince Charming of China’s A-share market.
READ
Lily & Beauty is the largest one-stop online retailer of beauty products in China and the world’s largest provider of online counters for cosmetic brands.
READOver the past year, the bull market returned, with technology leading the way.
As I said back in October 2024, the rally that began on September 24 was not merely a rebound, but a reversal. Since then, China's capital markets have undergone a broad revaluation, moving from undervaluation toward fair value.
The Shanghai Composite Index reached its highest level in a decade. The "Yi-Zhong-Tian" trio—Eoptolink, Zhongji Innolight and TFC Communication, three prominent Chinese optical communications stocks—saw their share prices multiply severalfold in a single year. Cambricon's market capitalization briefly exceeded RMB 600 billion. Elsewhere in the technology sector, triple-digit price-to-earnings ratios and valuations exceeding RMB 10 billion became commonplace.
Some investors were greedy; others, fearful. Still others asked me: Are technology stocks in a valuation bubble?
My answer is that what we are witnessing is the hunger and anxiety of an era, reflected in the capital markets. Once you understand this, the current fervor for technology investing is no longer difficult to explain.
Investment has nothing to do with macroeconomics, but everything to do with geopolitics.
China-US relations will shape the investment landscape for decades to come. Geopolitics has played a major role in shaping the hunger and anxiety of our times, fundamentally reshaping the way we invest.
What, then, lies at the heart of China's hunger and anxiety?
The Fourth Industrial Revolution is already underway, yet China has not fully overcome the technological shortcomings left by the Third. There is no time to lose.
This is why some people wonder: Why do Chinese computing chip companies command such high valuations when their technologies still lag so far behind NVIDIA's? Why does NVIDIA trade at just 50 times earnings, while a company hailed as "China's answer to NVIDIA" commands a multiple of 300?
To me, this gets the logic exactly backward.
It is precisely because these companies cannot catch up with NVIDIA in the near term that they command a higher strategic premium. The wider the technological gap, the greater the strategic value.
The further something lies beyond our reach, the stronger our hunger. The harder it is to catch up, the deeper our anxiety. If China were to achieve a complete breakthrough in computing chips one day, valuations might actually come down.
Where can one find China's most spectacular natural landscapes?
Much of the answer, I believe, lies in and around the Hengduan Mountains: the Meili Snow Mountains, Jade Dragon Snow Mountain, Mount Gongga, Mount Siguniang, Jiuzhaigou, and many others. Vast differences in elevation and deep fault lines have given rise to landscapes of extraordinary grandeur.
Hard-tech investing follows a similar logic.
Technological gaps, discontinuities in capabilities, and missing links in industrial systems: a leap in difficulty brings a leap in valuation, and a successful breakthrough can, in turn, bring a leap in returns.
This logic extends well beyond computing chips. It is equally evident in memory semiconductors, commercial spaceflight, and other sectors where China still faces substantial technological gaps with other countries.
It was precisely this conviction that led CoStone Capital, starting in 2016, to decisively focus its investments on three areas: hard tech, emerging industries, and life sciences and healthcare. In this context, "hard tech" refers specifically to important industries in which China faces a technological gap with the United States.
Thanks to this forward-looking strategy, CoStone Capital established an early presence across the full value chains of key sectors, including semiconductors, artificial intelligence, and robotics.
Looking ahead, the frontiers of technological progress and industrial upgrading are boundless. Nor can the gaps in hard technology be closed overnight. The twin windows of opportunity presented by technological innovation and the development of homegrown alternatives to foreign technologies have only just begun to open.
The road ahead is long, but the future holds immense promise.
As an investment firm, CoStone Capital will continue to invest where the hunger and anxiety of each era run deepest, move forward with the tensions that shape our times, and extend our reach toward the most challenging—and most important—frontiers.
Spring 2026